Monthly Archives: March 2018

The U.S. Food and Drug Administration issued a draft guidance in March proposing to regulate medicines that are produced in bulk by compounding pharmacies.

PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.

Acute or irregular flushing may signal a more serious health condition, say researchers who highlight 14 questions physicians should ask patients complaining about unusual flushing.

The transcription factor “retinoid-related orphan receptor-alpha” (RORA) has been identified as a regulator of T regulatory (Treg) genes responsible for suppressing allergic skin inflammation, researchers report.

While antibiotics are a proven effective treatment for recurrent cellulitis, the effect wears off after treatment which is often done on an inpatient basis. There is little support for ongoing research in this area, researchers report.